|
市場調査レポート
米国における創薬受託研究機関市場
U.S. Drug Discovery Contract Research Organization Markets
|
Abstract
Research Overview
This research service is available through our Pharmaceuticals & Clinical
Diagnostics Growth Partnership Service program. With this program, you receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils
Table of Contents
- 1. Executive Summary
- 2. Overview
- 1. Overview
- 1. Introduction
- 2. Market Segmentation
- 3. Research Methodology
- 4. Market Engineering Measurements
- 3. U.S. Drug Discovery Contract Research Organization Markets
- 1. Market Drivers Restraints and Trends
- 1. Market Drivers
- a. Cost Pressures Encourage Research and Development (R&D) Outsourcing
- b. Strong Growth of R&D Expenditure by Pharmaceutical and
Biotechnology Companies Spurs Market Expansion
- c. Aging Population and Shift from Acute to Chronic Products Drives
Demand for Outsourcing
- d. Limited Development Infrastructure with Biotechnology and Specialty
Pharmaceutical Encourages Demand for Outsourcing
- e. Robust Biotechnology Funding Drives Outsourcing Volumes
- f. Toxicology Capacity Addition by Outsourcers Encourages Outsourcing
Market Expansion
- 2. Market Restraints
- a. Increasing Competition and Commoditization of CRO Services Curtails
Margins
- b. Increasingly Stringent Regulatory Standards Pose an Ongoing Quality
Challenge for CROs
- c. Consolidation of the Pharmaceutical Industry Reduces Potential
Revenues for Contract Research
- d. Small CRO Size Limits Breadth of Offerings, While, Large Size
Limits Flexibility
- 3. Market Trends
- 2. Revenue Forecasts Demand Analysis and Competitive Structure
- 1. Revenue Forecasts
- 2. Demand Analysis
- 3. Competitive Structure
- 3. Competitive Analysis
- 4. Frost and Sullivan Awards
- 1. Business Development Strategy Leadership Award
- 2. Growth Strategy Leadership Award
- 3. Market Leadership Award
- 4. Challenges and Strategies
- 1. Industry Challenges & Strategies
- 1. Industry Challenges
- 2. Strategies
- 5. Decision Support Databases
- 1. Pharmaceuticals and Biotechnology
- 1. Pharmaceutical Research and Development Expenditure
- 2. Biotechnology Companies
- 3. Private Investment in Biotechnology Companies
- 4. Biotechnology Government Research and Development Expenditure
- 2. Macro Economic and Demographic Indicators
- 1. Nominal GDP Growth
- 2. Total Population
|
